{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T03:36:29Z","timestamp":1776656189812,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,19]]},"DOI":"10.7759\/cureus.107365","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:41:04Z","timestamp":1776652864000},"source":"Crossref","is-referenced-by-count":0,"title":["An Updated Systematic Review of Topical Corticosteroid Withdrawal (TCSW): Steroid Addiction or Adverse Drug Effect?"],"prefix":"10.7759","author":[{"given":"Hunjung","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Orbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahla","family":"Esam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield LF","year":"2014","unstructured":"Eichenfield LF, Tom WL, Berger TG, et al.. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014, 71:116-32. 10.1016\/j.jaad.2014.03.023","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15194","article-title":"Topical steroid withdrawal through the lens of social media","volume":"47","author":"Bowe S","year":"2022","unstructured":"Bowe S, Masterson S, Murray G, Haugh I. Topical steroid withdrawal through the lens of social media. Clin Exp Dermatol. 2022, 47:1554-7. 10.1111\/ced.15194","journal-title":"Clin Exp Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15269","article-title":"Steroid phobia on social media platforms","volume":"40","author":"Nickles MA","year":"2023","unstructured":"Nickles MA, Coale AT, Henderson WJ, Brown KE, Morrell DS, Nieman EL. Steroid phobia on social media platforms. Pediatr Dermatol. 2023, 40:479-82. 10.1111\/pde.15269","journal-title":"Pediatr Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llac019","article-title":"#corticophobia: a review on online misinformation related to topical steroids","volume":"48","author":"Finnegan P","year":"2023","unstructured":"Finnegan P, Murphy M, O'Connor C. #corticophobia: a review on online misinformation related to topical steroids. Clin Exp Dermatol. 2023, 48:112-5. 10.1093\/ced\/llac019","journal-title":"Clin Exp Dermatol"},{"key":"ref5","unstructured":"Topical steroid withdrawal. what the eczema community needs to know, now. (2022). Accessed: October 23, 2025: https:\/\/nationaleczema.org\/blog\/tsw-need-to-know\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\"steroid addiction\") in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar T","year":"2015","unstructured":"Hajar T, Leshem YA, Hanifin JM, et al.. A systematic review of topical corticosteroid withdrawal (\"steroid addiction\") in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015, 72:541-9.e2. 10.1016\/j.jaad.2014.11.024","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1882659","article-title":"Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review","volume":"33","author":"Hwang J","year":"2022","unstructured":"Hwang J, Lio PA. Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review. J Dermatolog Treat. 2022, 33:1293-8. 10.1080\/09546634.2021.1882659","journal-title":"J Dermatolog Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.09.031","article-title":"Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey","volume":"130","author":"Barta K","year":"2023","unstructured":"Barta K, Fonacier LS, Hart M, Lio P, Tullos K, Sheary B, Winders TA. Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey. Ann Allergy Asthma Immunol. 2023, 130:93-99.e10. 10.1016\/j.anai.2022.09.031","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref9","unstructured":"Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). (2011). Accessed. October 23, 2025: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/explanation-of-the-2011-ocebm-levels-of-evidence."},{"key":"ref10","unstructured":"OCEBM Levels of Evidence. (2011). Accessed. October 23, 2025: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-06","article-title":"Systematic reviews of etiology and risk","author":"Moola S","year":"2024","unstructured":"Moola S, Munn Z, Tufanaru C, et al.. Systematic reviews of etiology and risk. JBI Manual for Evidence Synthesis. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (ed): JBI, Adelaide; 2024. 10.46658\/JBIMES-24-06"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn Z","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, et al.. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020, 18:2127-33. 10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1239869","article-title":"JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series","volume":"10","author":"Xu B","year":"2023","unstructured":"Xu B, Xu Z, Ye S, Sun H, Zhao B, Wu N, Wu J. JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series. Front Med (Lausanne). 2023, 10:1239869. 10.3389\/fmed.2023.1239869","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_495_21","article-title":"Role of botulinum toxin in the management of topical corticosteroid induced rosacea like dermatitis: a case report","volume":"13","author":"Katoch S","year":"2022","unstructured":"Katoch S, Barua TN, Barua KN. Role of botulinum toxin in the management of topical corticosteroid induced rosacea like dermatitis: a case report. Indian Dermatol Online J. 2022, 13:395-7. 10.4103\/idoj.idoj_495_21","journal-title":"Indian Dermatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X231164268","article-title":"Topical steroid withdrawal syndrome in a mother and son: a case report","volume":"11","author":"Feschuk AM","year":"2023","unstructured":"Feschuk AM, Pratt ME. Topical steroid withdrawal syndrome in a mother and son: a case report. SAGE Open Med Case Rep. 2023, 11:2050313X231164268. 10.1177\/2050313X231164268","journal-title":"SAGE Open Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14469","article-title":"Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis","volume":"21","author":"Konu\u015f A","year":"2022","unstructured":"Konu\u015f A, Ertu\u011frul G, Akta\u015f H. Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis. J Cosmet Dermatol. 2022, 21:2686-7. 10.1111\/jocd.14469","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S392280","article-title":"Tofacitinib for the treatment of steroid-induced rosacea","volume":"15","author":"Li T","year":"2022","unstructured":"Li T, Wang H, Wang C, Hao P. Tofacitinib for the treatment of steroid-induced rosacea. Clin Cosmet Investig Dermatol. 2022, 15:2519-21. 10.2147\/CCID.S392280","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.7638","article-title":"Sarecycline as a potential treatment for steroid-induced rosacea\/perioral dermatitis: a case report","volume":"23","author":"Sher A","year":"2024","unstructured":"Sher A, Kresch M, Bitterman D, Elbogen E, Lebwohl MG. Sarecycline as a potential treatment for steroid-induced rosacea\/perioral dermatitis: a case report. J Drugs Dermatol. 2024, 23:e55-6. 10.36849\/JDD.7638","journal-title":"J Drugs Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000387","article-title":"Steroid withdrawal effects following long-term topical corticosteroid use","volume":"29","author":"Sheary B","year":"2018","unstructured":"Sheary B. Steroid withdrawal effects following long-term topical corticosteroid use. Dermatitis. 2018, 29:213-8. 10.1097\/DER.0000000000000387","journal-title":"Dermatitis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15356","article-title":"Platelet rich plasma in treatment of topical steroid damaged face: a retrospective analytical study","volume":"35","author":"Majid I","year":"2022","unstructured":"Majid I, Timungpi R. Platelet rich plasma in treatment of topical steroid damaged face: a retrospective analytical study. Dermatol Ther. 2022, 35:e15356. 10.1111\/dth.15356","journal-title":"Dermatol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00492-1","article-title":"Successful treatment of corticosteroid-induced rosacea-like dermatitis with platelet-rich plasma mesotherapy: report of seven cases","volume":"11","author":"Fan X","year":"2021","unstructured":"Fan X, Yin Y, Dou W, Li T, Xue P, Yang Q, Ma Q. Successful treatment of corticosteroid-induced rosacea-like dermatitis with platelet-rich plasma mesotherapy: report of seven cases. Dermatol Ther (Heidelb). 2021, 11:615-23. 10.1007\/s13555-021-00492-1","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14443","article-title":"Topical steroid-induced perioral dermatitis (TOP STRIPED): case report of a man who developed topical steroid-induced rosacea-like dermatitis (TOP SIDE RED)","volume":"13","author":"Diehl KL","year":"2021","unstructured":"Diehl KL, Cohen PR. Topical steroid-induced perioral dermatitis (TOP STRIPED): case report of a man who developed topical steroid-induced rosacea-like dermatitis (TOP SIDE RED). Cureus. 2021, 13:e14443. 10.7759\/cureus.14443","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462076-an-updated-systematic-review-of-topical-corticosteroid-withdrawal-tcsw-steroid-addiction-or-adverse-drug-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:41:06Z","timestamp":1776652866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462076-an-updated-systematic-review-of-topical-corticosteroid-withdrawal-tcsw-steroid-addiction-or-adverse-drug-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.107365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,19]]}}}